Descazeaud A - Search Results

1

Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays.

Beroukhim R, Lin M, Park Y, Hao K, Zhao X, Garraway LA, Fox EA, Hochberg EP, Mellinghoff IK, Hofer MD, Descazeaud A, Rubin MA, Meyerson M, Wong WH, Sellers WR, Li C. Beroukhim R, et al. Among authors: descazeaud a. PLoS Comput Biol. 2006 May;2(5):e41. doi: 10.1371/journal.pcbi.0020041. Epub 2006 May 12. PLoS Comput Biol. 2006. PMID: 16699594 Free PMC article.

2

Characterization of ZAG protein expression in prostate cancer using a semi-automated microscope system.

Descazeaud A, de la Taille A, Allory Y, Faucon H, Salomon L, Bismar T, Kim R, Hofer MD, Chopin D, Abbou CC, Rubin MA. Descazeaud A, et al. Prostate. 2006 Jul 1;66(10):1037-43. doi: 10.1002/pros.20405. Prostate. 2006. PMID: 16598739

3

BPH gene expression profile associated to prostate gland volume.

Descazeaud A, Rubin MA, Hofer M, Setlur S, Nikolaief N, Vacherot F, Soyeux P, Kheuang L, Abbou CC, Allory Y, de la Taille A. Descazeaud A, et al. Diagn Mol Pathol. 2008 Dec;17(4):207-13. doi: 10.1097/PDM.0b013e31816f6352. Diagn Mol Pathol. 2008. PMID: 18936709 Free PMC article.

4

[Molecular signature of BPH].

de la Taille A, Descazeaud A, Rubin M. de la Taille A, et al. Among authors: descazeaud a. Prog Urol. 2005 Dec;15(6 Suppl 1):1314-5. Prog Urol. 2005. PMID: 16734222 French. No abstract available.

5

Evolution of health-related quality of life two to seven years after retropubic radical prostatectomy: evaluation by UCLA prostate cancer index.

Descazeaud A, Zerbib M, Hofer MD, Chaskalovic J, Debré B, Peyromaure M. Descazeaud A, et al. World J Urol. 2005 Sep;23(4):257-62. doi: 10.1007/s00345-005-0004-8. Epub 2005 Sep 1. World J Urol. 2005. PMID: 16136358

6

What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?

Descazeaud A, Rubin MA, Allory Y, Burchardt M, Salomon L, Chopin D, Abbou C, de la Taille A. Descazeaud A, et al. Eur Urol. 2005 Dec;48(6):911-5. doi: 10.1016/j.eururo.2005.07.011. Epub 2005 Aug 9. Eur Urol. 2005. PMID: 16140457

7

Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation.

Descazeaud A, Weinbreck N, Robert G, Vacherot F, Abbou CC, Labrousse F, Allory Y, Rubin MA, de la Taille A. Descazeaud A, et al. BJU Int. 2011 Jul;108(2 Pt 2):E23-8. doi: 10.1111/j.1464-410X.2010.09699.x. Epub 2010 Sep 14. BJU Int. 2011. PMID: 20840324 Free article.

8

Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen.

Descazeaud A, Rubin M, Chemama S, Larré S, Salomon L, Allory Y, Vordos D, Hoznek A, Yiou R, Chopin D, Abbou C, de la Taille A. Descazeaud A, et al. World J Urol. 2006 Dec;24(6):676-80. doi: 10.1007/s00345-006-0134-7. Epub 2006 Nov 7. World J Urol. 2006. PMID: 17089179

9

Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.

Robert G, Descazeaud A, Nicolaïew N, Terry S, Sirab N, Vacherot F, Maillé P, Allory Y, de la Taille A. Robert G, et al. Among authors: descazeaud a. Prostate. 2009 Dec 1;69(16):1774-80. doi: 10.1002/pros.21027. Prostate. 2009. PMID: 19670242 Free PMC article.

10

Extended biopsy protocol decreases prostate cancer incidence and risk of aggressive disease on repeated biopsies compared with initial standard procedure.

Ploussard G, Bastien L, Descazeaud A, Robert G, Allory Y, Salomon L, Vordos D, Hoznek A, Yiou R, Abbou CC, de la Taille A. Ploussard G, et al. Among authors: descazeaud a. Urol Int. 2010;84(2):147-52. doi: 10.1159/000277590. Epub 2010 Mar 4. Urol Int. 2010. PMID: 20215817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page